Login to Your Account

Galapagos gets $180M for Biofocus, Argenta discovery service units

By Cormac Sheridan
Staff Writer

Thursday, March 13, 2014
Shares in Galapagos NV gained 11 percent Thursday morning on news that it sold its Biofocus and Argenta drug discovery services units to Charles River Laboratories International Inc. for €129 million (US$180 million) in cash, with another potential 5 million earnout to come.

To continue reading subscribe now to Latest News

Learn More about Latest News

Already a subscriber? Sign In or Buy now to activate your subscription